3-[[6-[1-[(2-methylpropan-2-yl)oxycarbonyl]-2,3-dihydroindol-6-yl]indol-1-yl]methyl]benzoic acid
C29H28N2O4 — CID 146001039
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-[[6-[1-[(2-methylpropan-2-yl)oxycarbonyl]-2,3-dihydroindol-6-yl]indol-1-yl]methyl]benzoic acid
3-[[6-[1-[(2-methylpropan-2-yl)oxycarbonyl]-2,3-dihydroindol-6-yl]indol-1-yl]methyl]benzoic acid (PubChem CID 146001039) has the molecular formula C29H28N2O4 and a molecular weight of 468.55 g/mol. Its IUPAC name is 3-[[6-[1-[(2-methylpropan-2-yl)oxycarbonyl]-2,3-dihydroindol-6-yl]indol-1-yl]methyl]benzoic acid.
Molecular Properties
| Compound Name | 3-[[6-[1-[(2-methylpropan-2-yl)oxycarbonyl]-2,3-dihydroindol-6-yl]indol-1-yl]methyl]benzoic acid |
|---|---|
| PubChem CID | 146001039 |
| Molecular Formula | C29H28N2O4 |
| Molecular Weight | 468.55 g/mol |
| Exact Mass | 468.20 |
| IUPAC Name | 3-[[6-[1-[(2-methylpropan-2-yl)oxycarbonyl]-2,3-dihydroindol-6-yl]indol-1-yl]methyl]benzoic acid |
| SMILES | CC(C)(C)OC(=O)N1CCc2ccc(-c3ccc4ccn(Cc5cccc(C(=O)O)c5)c4c3)cc21 |
| InChI | InChI=1S/C29H28N2O4/c1-29(2,3)35-28(34)31-14-12-21-8-10-23(17-26(21)31)22-9-7-20-11-13-30(25(20)16-22)18-19-5-4-6-24(15-19)27(32)33/h4-11,13,15-17H,12,14,18H2,1-3H3,(H,32,33) |
| InChIKey | SWSVUTNPZQDPGU-UHFFFAOYSA-N |
| XLogP | 6.35 |
| TPSA | 71.77 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 35 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 468.55 |
| LogP ≤ 5 | 6.35 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 146001039 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.